Success Metrics

Clinical Success Rate
87.5%

Based on 35 completed trials

Completion Rate
88%(35/40)
Active Trials
8(12%)
Results Posted
29%(10 trials)
Terminated
5(8%)

Phase Distribution

Ph phase_2
19
29%
Ph phase_3
4
6%
Ph phase_1
5
8%
Ph not_applicable
29
44%
Ph phase_4
7
11%
Ph early_phase_1
2
3%

Phase Distribution

7

Early Stage

19

Mid Stage

11

Late Stage

Phase Distribution66 total trials
Early Phase 1First-in-human
2(3.0%)
Phase 1Safety & dosage
5(7.6%)
Phase 2Efficacy & side effects
19(28.8%)
Phase 3Large-scale testing
4(6.1%)
Phase 4Post-market surveillance
7(10.6%)
N/ANon-phased studies
29(43.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.4%

35 of 43 finished

Non-Completion Rate

18.6%

8 ended early

Currently Active

8

trials recruiting

Total Trials

66

all time

Status Distribution
Active(13)
Completed(35)
Terminated(8)
Other(10)

Detailed Status

Completed35
unknown10
Recruiting6
Terminated5
Not yet recruiting5
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
66
Active
8
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.0%)
Phase 15 (7.6%)
Phase 219 (28.8%)
Phase 34 (6.1%)
Phase 47 (10.6%)
N/A29 (43.9%)

Trials by Status

terminated58%
active_not_recruiting23%
completed3553%
recruiting69%
unknown1015%
withdrawn35%
not_yet_recruiting58%

Recent Activity

Clinical Trials (66)

Showing 20 of 66 trialsScroll for more
NCT07537283Not Applicable

Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy

Completed
NCT03113994Phase 2

Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

Terminated
NCT07096557Phase 2

The Effect of Co-enzyme Q10 on the Clinical Outcome of Pediatric Patients With Systemic Lupus Erythematosus

Completed
NCT07260773Not Applicable

The Effects of Coenzyme Q10 Pretreatment on Ovarian Function and Assisted Reproductive Outcomes in Patients With Ovarian Hyporesponsiveness.

Not Yet Recruiting
NCT07255079Not Applicable

A Clinical Trial to Assess the Pharmacokinetic Profile of Three Coenzyme Q10 Formulations in Healthy Adults

Not Yet Recruiting
NCT04972552Not Applicable

Watermelon/UBIQuinone Study

Active Not Recruiting
NCT05942027Phase 4

Role of Coenzyme Q10 in Chronic Kidney Disease

Recruiting
NCT06856447Phase 1

The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

Recruiting
NCT05873673Phase 2

Coenzyme Q10 and Dentoalveolar Cyst

Active Not Recruiting
NCT06743802Phase 4

The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery

Recruiting
NCT04444349Not Applicable

Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)

Recruiting
NCT06659406Not Applicable

Effect of Coenzyme Q10 Administration on Polycystic Ovary Syndrome

Not Yet Recruiting
NCT06506630Not Applicable

Effects of Coenzyme Q10 Supplement on Cardiovascular Risk Factors in Subjects at High Risk of Metabolic Syndrome

Recruiting
NCT03831425Phase 2

Mitochondrial Complex I Dysfunction in PWS

Withdrawn
NCT06405204Phase 3

of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

Not Yet Recruiting
NCT00243932Phase 2

Clinical Trial of High Dose CoQ10 in ALS

Completed
NCT06089395Early Phase 1

The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)

Not Yet Recruiting
NCT06391606Not Applicable

CoQ10 in Statin-associated Asthenia

Completed
NCT06040905Not Applicable

Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic Factor

Recruiting
NCT05293132Phase 2

Effect of Montelukast Versus Co Enzyme in Sepsis

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
66